There are 700,000 total knee replacement surgeries and 300,000 total hip replacements performed in the US each year. Those numbers are expected to grow to 3.5 million and 500,000 respectively by the year 2030 as the baby boom generation ages.
While a joint replacement can provide complete pain relief and return of joint function for most patients, these major orthopedic surgeries can result in the development of venous thromboembolisms (VTEs) including deep vein thromboses (DVTs) and pulmonary embolisms (PEs).
To help prevent these potentially fatal complications, the American College of Chest Physicians recommends that patients who have undergone major orthopedic surgery use a compression therapy device to help prevent the development of VTEs for 18 hours a day for 10 to 35 days after the patient is discharged from the hospital.
However, existing compression devices severely limit a patient’s mobility, are noisy and provide no feedback to clinicians regarding compliance. As a result, most patients don’t comply with the College’s standard which can result in unplanned readmissions.
The Cirvo Compression System is a truly wearable, connected, battery operated intermittent compression device that is portable and unobtrusive. It is powered by a dedicated app that delivers your personalized therapy parameters and monitors your progress over time. The connected app also the physician to monitor patients’ progress and adjust their therapy if necessary.
We at Radial Medical are dedicated to transforming the experience of compression therapy in a way that will both increase patient comfort and compliance as well as reduce the incidence of costly readmissions.